# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA641277 | F | Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP | 1 | ALA1129369 | assay format | Scientific Literature | ||
2. | ALA643972 | B | Displacement of [125I]6-IHPP-Fsk from adenylate cyclase of bovine brain membrane | Bos taurus | 13 | ALA1125913 | tissue-based format | Scientific Literature | |
3. | ALA646259 | F | Effect of compound on cellular c-AMP levels by activation of Adenylate cyclase | 6 | ALA1133882 | assay format | Scientific Literature | ||
4. | ALA645667 | F | Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1 | 45 | ALA1129369 | assay format | Scientific Literature | ||
5. | ALA645668 | B | Inhibition of [125 I]6-IHPP-forskolin binding to adenylate cyclase 1 | 45 | ALA1129369 | assay format | Scientific Literature | ||
6. | ALA645672 | F | Maximum stimulation activity measured with 100 uM forskolin mediated by adenylate cyclase 1 | 39 | ALA1129369 | assay format | Scientific Literature | ||
7. | ALA645673 | B | Inhibition of [125 I]6-IHPP-forskolin binding to Adenylate cyclase 1 | 1 | ALA1129369 | assay format | Scientific Literature | ||
8. | ALA657722 | F | Effective dose for lowering blood pressure in anesthetized cat when administered intravenously | Felis catus | 53 | ALA1123969 | organism-based format | Scientific Literature | |
9. | ALA661349 | F | Percent activation of wild type CFTR dependent efflux was determined by measuring the rate of iodide [125I]- efflux from transfected CHO cells | 26 | ALA1148470 | cell-based format | Scientific Literature | ||
10. | ALA668619 | F | Dose required to produce 50 % increase in left ventricular dP/dt max in anesthetized dogs when administered intravenously | Canis lupus familiaris | 7 | ALA1123969 | organism-based format | Scientific Literature | |
11. | ALA678528 | F | Positive inotropic activity in spontaneously beating guinea pig atria | Cavia porcellus | 44 | ALA1123969 | organism-based format | Scientific Literature | |
12. | ALA684234 | B | Inhibition of [125I]7-IHPP-Fsk binding to glucose transporter of human erythrocyte membrane | Homo sapiens | 13 | ALA1125913 | assay format | Scientific Literature | |
13. | ALA690192 | F | Percent increase in the Forskolin-Stimulated cAMP formation, in HeLa cells transfected with the 5-HT 1A receptor at 10 uM concentration | Homo sapiens | 1 | ALA1134339 | cell-based format | Scientific Literature | |
14. | ALA695976 | F | Effect on Forskolin-Stimulated cAMP formation, in HeLa cells transfected with the 5-HT 1A receptor at 10 uM concentration | Homo sapiens | 1 | ALA1134339 | cell-based format | Scientific Literature | |
15. | ALA698851 | F | Compound was testd for inhibition of glucose transport human erythrocytes using [H]-forskolin as radioligand | Homo sapiens | 1 | ALA1131766 | organism-based format | Scientific Literature | |
16. | ALA702041 | F | Compound was testd for inhibition of glucose transport human platelets using [H]-forskolin as radioligand | Homo sapiens | 1 | ALA1131766 | organism-based format | Scientific Literature | |
17. | ALA737415 | T | Acute toxicity in mice when administered intraperitoneally | Mus musculus | 7 | ALA1123969 | organism-based format | Scientific Literature | |
18. | ALA763520 | F | Cytotoxicity in HPBMC (Human Peripheral Blood Mononuclear Cells); Not active | Homo sapiens | 6 | ALA1136231 | assay format | Scientific Literature | |
19. | ALA765508 | F | Inhibition efficacy of TNF-alpha was tested in HPBMC (Human Peripheral Blood Mononuclear Cells); Not active | Homo sapiens | 3 | ALA1136231 | assay format | Scientific Literature | |
20. | ALA760967 | F | Inhibition of TNF-alpha was tested in HPBMC (Human Peripheral Blood Mononuclear Cells); inactive | Homo sapiens | 1 | ALA1136231 | assay format | Scientific Literature |